A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(19 sites)

United States

Colorado Springs Neurological Associates, Colorado Springs, Colorado

Medstar Health Research Institute, Washington D.C., District of Columbia

Gables Neurology, Miami, Florida

Paradigm Health System, Slidell, Louisiana

National Neuromuscular Research Institute, Austin, Texas

NeuroCarePlus, Houston, Texas

China

Peking University First Hospital - Changqiao Campus, Beijing

Nanfang Hospital Southern Medical University, Guangzhou

Georgia

High Technology Hospital MedCenter Ltd, Batumi

First Medical Clinic LLC, Batumi

Petre Sarajishvili Institute of Neurology, Tbilisi

Aleksandre Aladashvili Clinic, Tbilisi

Curatio JSC, Tbilisi

LTD New Hospitals, Tbilisi

Geo Hospitals, Tbilisi

Jo Ann Medical Center, Tbilisi

Japan

Southern TOHOKU Medical Clinic, Kōriyama

South Korea

Seoul National University Hospital, Seoul

Korea University Guro Hospital, Seoul